Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB25FW2NY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $54,815
Award facts
- Contract value 100% obligated
- $54,815.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $54,815.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3ml injections. The contract, which became effective on July 15, 2025, with an ultimate completion date of July 16, 2025, represents a competitively awarded, non-set-aside procurement from the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, regularly fulfills delivery orders for the Defense Logistics Agency's medical supply chain across multiple therapeutic domains. The company's substantial IDC with DLA Troop Support Medical serves as a flexible contracting vehicle supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with specialty medications, brand-name and generic drugs, vaccines, and related medical supplies. This specific delivery order for Ozempic, a diabetes medication, exemplifies the routine pharmaceutical procurement activities executed through AmerisourceBergen's established federal contract relationships with the Department of Defense logistics infrastructure.
Quick answers
Who was awarded contract SPE2DB25FW2NY?
SPE2DB25FW2NY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 15, 2025.
How much is contract SPE2DB25FW2NY worth?
The government has obligated $54,815 on SPE2DB25FW2NY.
Is contract SPE2DB25FW2NY an order under another contract?
Yes. SPE2DB25FW2NY is a delivery order under SPE2DB22D2006, an indefinite delivery contract.
Was contract SPE2DB25FW2NY competed?
The extent of competition for SPE2DB25FW2NY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award